Christopher H. Morrell

Christopher H. Morrell

Auto-generated profile, based on publicly available information

Christopher H. Morrell

National Institute on Aging Intramural Research Program, National Institutes of Health

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2022 in GeroScience
Verified
Journal Article
Open access
PDF file
MAMajd AlGhatrif
Majd AlGhatrif
ELEdward Lakatta
Edward Lakatta
CMChristopher H. Morrell
Christopher H. Morrell
DFDanilo Alunni Fegatelli
Danilo Alunni Fegatelli
EFEdoardo Fiorillo
Edoardo Fiorillo
ASAngelo Scuteri
Angelo Scuteri
Hypertrophic carotid geometric phenotypes (h-CGP) are predictors of incident cardiovascular disease (CVD). While arterial aging is hypothesized as a contri

20 May 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
RORichard Oppong
Richard Oppong
VOValeria Orrù
Valeria Orrù
MMMichele Marongiu
Michele Marongiu
YQYong Qian
Yong Qian
CSCarlo Sidore
Carlo Sidore
ASAngelo Scuteri
Angelo Scuteri
Background: Growth differentiation factor 15 (GDF‐15) levels are emerging as a candidate biomarker of aging. The present study aimed to: (1) characterize the association of GDF‐15 with the continuum of arterial stiffening, assessed as carotid‐femoral pulse wave velocity, as age increases; (2) determine the predictive role of serum GDF‐15 levels on mortality; and (3) identify genetic determinants of serum GDF‐15 levels. Methods and Results: Serum levels of GDF‐15 and established cardiovascular risk factors, including pulse wave velocity, were assessed in a large (4736 individual) Sardinian population. Serum levels of GDF‐15, which can be reliably measured repeatedly over time, increase with age; are associated with a stiffer aorta; “mediate” a large proportion of the age‐associated increase in arterial stiffness; pose risks because of their association with greater mortality; and are significantly associated with the variant rs11549407, which causes thalassemia major in homozygosity. Conclusions: Because of its consistent ability to predict functional and clinical outcomes, including all‐cause mortality, we conclude that GDF‐15 serum levels serve as a robust biomarker for the continuum from health to the emergence of clinical disease during aging and, subsequently, to the likelihood of mortality.

6 August 2018 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
RKR. Jeffrey Karnes
R. Jeffrey Karnes
FMF. Roy MacKintosh
F. Roy MacKintosh
CMChristopher H. Morrell
Christopher H. Morrell
LRLori Rawson
Lori Rawson
PSPreston C. Sprenkle
Preston C. Sprenkle
TNThomas B. Neville
Thomas B. Neville
If prostate-specific antigen (PSA) trends help identify elevated prostate cancer (PCa) risk, they might provide early warning of progressing cancer for further evaluation and justify annual testing. Our objective was to determine whether PSA trends predict PCa likelihood. A biopsy cohort of 361,657 men was obtained from a Veterans Affairs database (1999–2012). PSA trends were estimated for the 310,458 men with at least 2 PSA tests prior to biopsy. Cancer tumors may grow exponentially with cells doubling periodically. We hypothesized that PSA from prostate cancer grows exponentially above a no cancer baseline. We estimated PSA trends on that basis along with five descriptive variables: last PSA before biopsy, growth rate in PSA from cancer above a baseline, PSA variability around the trend, number of PSA tests, and time span of tests. PSA variability is a new variable that measures percentage deviations of PSA tests from estimated trends with 0% variability for a smoothly increasing trend. Logistic regression models were used to estimate relationships between the probability of PCa at biopsy and the trend variables and age. All five PSA trend variables and age were significant predictors of prostate cancer at biopsy (p < 0.0001). An overall logistic regression model achieved an AUC of 0.67 for men with at least 4 tests over at least 3 years, which was a substantial improvement over a single PSA (AUC 0.58). High probability of PCa was associated with low PSA variability (smooth trends), high PSA, high growth rate, many tests over a long time-span and older age. For example, at 4.0 PSA the probability of cancer is 32% for 1 PSA test and increases to 68% for 8 tests over 7 years with smooth, fast growth (0% variability and 50% exponential growth). Our results show that smooth, fast exponential growth in PSA above a baseline predicts an increased probability of PCa. The probability increases as smooth (low variability) trends are observed for more tests over a longer time span, which makes annual testing worth considering. Worrisome PSA trends might be used to trigger further evaluation and continued monitoring of the trends—even at low PSA levels.

3 May 2005 in Journal of Clinical Epidemiology
Verified
Journal Article
Closed access
PDF file
LBLarry J. Brant
Larry J. Brant
SSShan L. Sheng
Shan L. Sheng
CMChristopher H. Morrell
Christopher H. Morrell
AZAlan B Zonderman
Alan B Zonderman

1 August 2024 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
MAMajd AlGhatrif
Majd AlGhatrif
CMChristopher H. Morrell
Christopher H. Morrell
JFJerome L. Fleg
Jerome L. Fleg
PCPaul Chantler
Paul Chantler
SNSamer S. Najjar
Samer S. Najjar
ELEdward Lakatta
Edward Lakatta
The age-associated decline in aerobic exercise performance over an average of 13 yr in community-dwelling healthy individuals is more closely associated with decreased peripheral oxygen utilization rather than decreased cardiac output. This association was more evident in older than younger individuals. These findings suggest that future studies with larger samples examine whether these associations vary across the age range and whether the decline in cardiac output plays a greater role earlier in life. In addition, studies focused on determinants of peripheral oxygen uptake by exercising muscle may guide the selection of preventive strategies designed to maintain physical fitness with advancing age.

1 January 2026 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
Sneha S PillaiSneha S Pillai
Sneha S Pillai
CMChristopher H. Morrell
Christopher H. Morrell
CSCarla Rocha Dos Santos
Carla Rocha Dos Santos
HLHari Vishal Lakhani
Hari Vishal Lakhani
BGBruno De Souza Goncalves
Bruno De Souza Goncalves
OFOlga V. Fedorova
Olga V. Fedorova
To our knowledge, the present study explored, for the first time, the direct sex-specific association of chronic kidney disease, cardiovascular disease, and cognitive function with a panel of fluid biomarkers of oxidative stress, inflammation, fibrosis, and neurodegeneration, including the novel profibrotic marker marinobufagenin. The study shows that dysregulated cardiac and neurodegeneration biomarkers, along with hypertension and cardiac remodeling, aggravate the progression of cognitive impairment in patients with chronic kidney disease (CKD) in a sex-specific manner.